Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

Q: What does CUSIP 05337M104 represent in this 13F holders report?

CUSIP 05337M104 is the security identifier for AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in Q2 2021?

78 institutional investors reported AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 05337M104

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
Shares outstanding: 98,762,388
Total 13F shares: 32,560,006
Share change: -74,133
Total reported value: $219,142,519
Put/Call ratio: 53%
Price per share: $6.73
Number of holders: 78
Value change: -$1,408,221
Number of buys: 36
Number of sells: 23

Quarterly Holders Quick Answers

What is CUSIP 05337M104?
CUSIP 05337M104 identifies AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 05337M104:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	5.8%	5,741,939	$51,907,000	—	31 Mar 2021	13F
Avoro Capital Advisors LLC	13F	Company	4.4%	4,365,000	$39,460,000	—	31 Mar 2021	13F
Vivo Capital, LLC	13F	Company	3%	2,937,093	$26,551,000	—	31 Mar 2021	13F
BRANDES INVESTMENT PARTNERS, LP	13F	Company	3%	2,934,241	$26,027,000	—	31 Mar 2021	13F
Polar Capital Holdings Plc	13F	Company	2.8%	2,794,673	$25,264,000	—	31 Mar 2021	13F
COWEN AND COMPANY, LLC	13F	Company	2.5%	2,495,573	$22,560,000	—	31 Mar 2021	13F
Jeffrey L. Gendell	13F	Individual	2%	1,933,837	$17,482,000	—	31 Mar 2021	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	1.1%	1,095,000	$9,899,000	—	31 Mar 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.94%	929,306	$8,401,000	—	31 Mar 2021	13F
Asymmetry Capital Management, L.P.	13F	Company	0.72%	712,371	$6,440,000	—	31 Mar 2021	13F
FRAZIER MANAGEMENT LLC	13F	Company	0.59%	578,104	$5,226,000	—	31 Mar 2021	13F
Samsara BioCapital, LLC	13F	Company	0.56%	549,250	$4,965,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	0.52%	509,284	$4,604,000	—	31 Mar 2021	13F
Altium Capital Management LLC	13F	Company	0.45%	440,589	$3,983,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.43%	427,676	$3,866,000	—	31 Mar 2021	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.4%	397,713	$3,573,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.31%	303,017	$2,739,000	—	31 Mar 2021	13F
David M. Knott	13F	Individual	0.28%	272,845	$2,467,000	—	31 Mar 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.26%	253,227	$2,296,000	—	31 Mar 2021	13F
IRIDIAN ASSET MANAGEMENT LLC/CT	13F	Company	0.25%	244,068	$2,206,000	—	31 Mar 2021	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.24%	234,122	$2,116,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.23%	224,078	$2,026,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.21%	212,000	$1,916,000	—	31 Mar 2021	13F
CIBC Private Wealth Group LLC	13F	Company	0.17%	165,355	$1,495,000	—	31 Mar 2021	13F
Tri Locum Partners LP	13F	Company	0.16%	160,256	$1,449,000	—	31 Mar 2021	13F
Edge Wealth Management LLC	13F	Company	0.13%	130,000	$1,175,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	0.12%	120,693	$1,091,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.12%	117,600	$1,063,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.12%	114,876	$1,038,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.11%	113,167	$1,023,000	—	31 Mar 2021	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.1%	99,764	$902,000	—	31 Mar 2021	13F
HighVista Strategies LLC	13F	Company	0.09%	93,059	$841,000	—	31 Mar 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.08%	79,205	$716,000	—	31 Mar 2021	13F
SCHULHOFF & CO INC	13F	Company	0.06%	61,000	$551,000	—	31 Mar 2021	13F
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV	13F	Company	0.06%	55,625	$503,000	—	31 Mar 2021	13F
SG3 Management, LLC	13F	Company	0.05%	50,000	$452,000	—	31 Mar 2021	13F
Janney Montgomery Scott LLC	13F	Company	0.05%	46,286	$418,000	—	31 Mar 2021	13F
Caption Management, LLC	13F	Company	0.04%	44,192	$400,000	—	31 Mar 2021	13F
Keel Point, LLC	13F	Company	0.04%	43,051	$389,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	42,445	$383,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	41,413	$374,000	—	31 Mar 2021	13F
Atom Investors LP	13F	Company	0.04%	37,569	$340,000	—	31 Mar 2021	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	0.04%	34,970	$316,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.03%	32,378	$293,000	—	31 Mar 2021	13F
EATON VANCE MANAGEMENT	13F	Company	0.03%	32,135	$291,000	—	31 Mar 2021	13F
Mariner, LLC	13F	Company	0.03%	31,129	$281,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.02%	20,781	$188,000	—	31 Mar 2021	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.02%	20,577	$186,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	19,854	$179,000	—	31 Mar 2021	13F
AVANTAX ADVISORY SERVICES, INC.	13F	Company	0.02%	19,500	$177,000	—	31 Mar 2021	13F

Institutional Holders of Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) as of Q2 2021

As of 30 Jun 2021, Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,560,006 shares. The largest 10 holders included RTW INVESTMENTS, LP, Avoro Capital Advisors LLC, BRANDES INVESTMENT PARTNERS, LP, Vivo Capital, LLC, Polar Capital Holdings Plc, COWEN AND COMPANY, LLC, GENDELL JEFFREY L, RENAISSANCE TECHNOLOGIES LLC, JANUS HENDERSON GROUP PLC, and FRAZIER MANAGEMENT LLC. This page lists 78 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.